Societal Cdmo Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 6.1, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2023. Average receivable collection period, for the Societal Cdmo Inc in Dec 31 2023 quarter, has decreased to 60 days, compared to 62 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 204 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 1802 to 1804.

What is Receivable Turnover Ratio?
What is Societal Cdmo Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SCTL Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	3.92 %	-13.64 %	-6.06 %	7.82 %	33.89 %
Y / Y Revenue Change	14.17 %	9.27 %	-5.84 %	1.57 %	8.86 %
Receivable Turnover Ratio (TTM)	6.1	5.93	5.59	5.59	5.66
SCTL's Total Ranking	# 1804	# 1802	# 2362	# 1156	# 1045
Accounts Receivable average collection period days	60	62	65	65	64
Seq. Receivable Change	12.22 %	-4.84 %	1.92 %	-4.52 %	-6.75 %
Seq. Revenue Change	17.5 %	8.22 %	1.26 %	-11.33 %	12.46 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 51
Healthcare Sector	# 205
Overall Market	# 1804

Receivable Turnover Ratio Statistics
High	Average	Low
0.7	0.55	0.4
(Mar 31 2020)		(Sep 30 2017)

SCTL Company Profile • Back to SCTL Efficiency Comparisons • Compare SCTL Receivables Turnover Ratio to its Competitors

Financial Statements
Societal Cdmo Inc 's Accounts Receivable	$ 17 Millions	Visit SCTL's Balance sheet
Societal Cdmo Inc 's Sales TTM	$ 95 Millions	Visit SCTL's Income Statement
Sources of SCTL's Revenues		Visit SCTL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SCTL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SCTL's Growth Rates	SCTL's Roa	SCTL's Inventory Turnover Ratio	SCTL's Dividend Comparisons
SCTL's Profitability Ratios	SCTL's Roi	SCTL's Asset Turnover Ratio	SCTL's Dividend Growth
SCTL's Valuation Ratios	SCTL's Roe	SCTL's Financial Strength Ratios	SCTL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Recursion Pharmaceuticals Inc	15.69	$ 44.575 Millions	$ 2.842 Millions
Talkspace Inc	15.31	$ 149.380 Millions	$ 9.757 Millions
Xortx Therapeutics inc	15.15	$ 0.919 Millions	$ 0.061 Millions
Milestone Scientific Inc	15.03	$ 9.793 Millions	$ 0.651 Millions
American Oncology Network Inc	14.86	$ 1,279.185 Millions	$ 86.111 Millions
Chemed Corporation	14.52	$ 2,264.417 Millions	$ 155.918 Millions
Icu Medical Inc	14.46	$ 2,259.126 Millions	$ 156.262 Millions
Burning Rock Biotech Limited	14.39	$ 75.696 Millions	$ 5.260 Millions
Lftd Partners Inc	14.38	$ 51.611 Millions	$ 3.588 Millions
Centogene N v	14.16	$ 54.319 Millions	$ 3.836 Millions
Patterson Companies Inc	14.11	$ 6,565.239 Millions	$ 465.318 Millions
Utah Medical Products Inc	14.01	$ 50.097 Millions	$ 3.575 Millions
Corcept Therapeutics Inc	13.70	$ 482.375 Millions	$ 35.215 Millions
Theralink Technologies Inc	13.67	$ 0.511 Millions	$ 0.037 Millions
Precipio inc	13.43	$ 15.197 Millions	$ 1.132 Millions
Protalix Biotherapeutics inc	13.39	$ 65.494 Millions	$ 4.890 Millions
Lifeloc Technologies Inc	13.20	$ 9.330 Millions	$ 0.707 Millions
Exact Sciences Corporation	13.11	$ 2,507.149 Millions	$ 191.178 Millions
Traws Pharma inc	12.91	$ 0.226 Millions	$ 0.018 Millions
Fate Therapeutics Inc	12.90	$ 63.533 Millions	$ 4.924 Millions
Ideaya Biosciences Inc	12.73	$ 23.385 Millions	$ 1.837 Millions
Amylyx Pharmaceuticals Inc	12.65	$ 380.786 Millions	$ 30.108 Millions
Valion Bio Inc	12.54	$ 1.176 Millions	$ 0.094 Millions
Teladoc Health Inc	12.18	$ 2,602.415 Millions	$ 213.613 Millions
International Stem Cell Corporation	12.13	$ 7.789 Millions	$ 0.642 Millions
Caribou Biosciences Inc	12.12	$ 34.477 Millions	$ 2.844 Millions
Zomedica Corp	12.01	$ 24.318 Millions	$ 2.025 Millions
Avita Medical Inc	11.98	$ 50.143 Millions	$ 4.185 Millions
Talis Biomedical Corporation	11.96	$ 2.134 Millions	$ 0.179 Millions
Nutriband Inc	11.81	$ 2.085 Millions	$ 0.177 Millions

Date modified: 2026-09-08T15:11:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.